| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IJROBP.2009.09.042 |
| P698 | PubMed publication ID | 20117285 |
| P50 | author | American College of Radiology | Q463714 |
| Louis Potters | Q40327316 | ||
| Minesh Mehta | Q56533682 | ||
| P2093 | author name string | James S Welsh | |
| David A Larson | |||
| James M Galvin | |||
| Seth A Rosenthal | |||
| American Society for Therapeutic Radiology and Oncology | |||
| Robert Timmerman | |||
| Nora A Janjan | |||
| Brian Kavanagh | |||
| Michael Steinberg | |||
| Samuel Ryu | |||
| James M Hevezi | |||
| P433 | issue | 2 | |
| P304 | page(s) | 326-332 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
| P1476 | title | American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy | |
| P478 | volume | 76 |
| Q94475153 | A Case of Solitary Lung Metastasis of Breast Cancer Successfully Treated with Stereotactic Body Radiotherapy after Chemotherapy |
| Q47101114 | A Unified Dose Response Relationship to Predict High Dose Fractionation Response in the Lung Cancer Stereotactic Body Radiation Therapy |
| Q26738278 | A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer |
| Q27000180 | A comprehensive review of contemporary role of local treatment of the primary tumor and/or the metastases in metastatic prostate cancer |
| Q41789184 | A randomised comparison of three different immobilisation devices for thoracic and abdominal cancers. |
| Q38806936 | A systematic and evidence-based approach to the management of vertebral metastasis |
| Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
| Q36356400 | Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors. |
| Q30993385 | Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy. |
| Q98771161 | Advances in Radiobiology of Stereotactic Ablative Radiotherapy |
| Q30421257 | American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS). |
| Q92103963 | Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review |
| Q36596607 | Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma |
| Q90811601 | Cancer du rein et radiothérapie : radiorésistance et au-delà |
| Q28083924 | Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy? |
| Q47767351 | Clinical commissioning and use of the Novalis Tx linear accelerator for SRS and SBRT. |
| Q37060393 | Clinical outcomes of video-assisted thoracic surgery and stereotactic body radiation therapy for early-stage non-small cell lung cancer: A meta-analysis |
| Q44946517 | Commissioning and initial stereotactic ablative radiotherapy experience with Vero |
| Q40835700 | Comparison of Clinical Outcomes of VATS and SBRT in the Treatment of NSCLC |
| Q60054013 | Comparison of Combination Stereotactic Body Radiotherapy Plus High-Intensity Focused Ultrasound Ablation Versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular Carcinoma |
| Q36936990 | Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma |
| Q37124697 | Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials. |
| Q53045959 | Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial. |
| Q39249966 | Cost-Effectiveness of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: a Critical Review |
| Q37468265 | Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer |
| Q55292088 | Developing rational combinations of immune checkpoint inhibitors and radiation therapy for gastrointestinal cancers. |
| Q28559861 | Development of patient-specific phantoms for verification of stereotactic body radiation therapy planning in patients with metallic screw fixation |
| Q60908706 | Developments in Stereotactic Body Radiotherapy |
| Q37524976 | Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016. |
| Q64388139 | Effects of different doses of X-ray irradiation on cell apoptosis, cell cycle, DNA damage repair and glycolysis in HeLa cells |
| Q35649048 | Efficacy and safety of image-guided interstitial single fraction high-dose-rate brachytherapy in the management of metastatic malignant melanoma |
| Q64950042 | Essential Concepts for the Management of Metastatic Spine Disease: What the Surgeon Should Know and Practice. |
| Q64236491 | Evaluation of dosimetric uncertainty caused by MR geometric distortion in MRI-based liver SBRT treatment planning |
| Q38135708 | Evolution of advanced technologies in prostate cancer radiotherapy |
| Q37956838 | Expanding the use of real-time electromagnetic tracking in radiation oncology |
| Q47142210 | Heart rate recovery and survival in patients undergoing stereotactic body radiotherapy for treatment of early-stage lung cancer |
| Q34508914 | High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma |
| Q37001905 | High-dose-rate interstitial brachytherapy for liver metastases: first study from India |
| Q34661001 | Hilar cholangiocarcinoma: diagnosis, treatment options, and management |
| Q90115551 | Hypofractionated 192Ir source stereotactic ablative brachytherapy with coplanar template assistance in the primary treatment of peripheral lung cancer |
| Q64095015 | Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years |
| Q36786770 | Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer |
| Q92189678 | Image guidance: past and future of radiotherapy |
| Q94046982 | Imaging as Part of a Quality Assurance Program: Predictors of Interobserver Variability for Pretreatment Image Registration for Lung SBRT |
| Q55398195 | Implications for high-precision dose radiation therapy planning or limited surgical resection after percutaneous computed tomography-guided lung nodule biopsy using a tract sealant. |
| Q33276219 | Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974-2011 |
| Q34762759 | Interfractional variations of tumor centroid position and tumor regression during stereotactic body radiotherapy for lung tumor |
| Q38677025 | Liver metastases and SBRT: A new paradigm? |
| Q90579412 | Local ablative radiotherapy for oligometastatic non-small cell lung cancer |
| Q47149089 | Low and medium doses of hypofractionated stereotactic radiotherapy could be suboptimal for early-stage lung cancer |
| Q38647568 | Lung Stereotactic Body Radiation Therapy. |
| Q36842981 | Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer |
| Q35710141 | Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy |
| Q37160539 | New paradigms and future challenges in radiation oncology: an update of biological targets and technology |
| Q52595063 | Non-invasive Cardiac Radiation for Ablation of Ventricular Tachycardia: a New Therapeutic Paradigm in Electrophysiology. |
| Q36803114 | Non-small cell lung cancer therapy: safety and efficacy in the elderly |
| Q89768426 | Noninvasive stereotactic radioablation for the treatment of atrial fibrillation: First-in-man experience |
| Q57469758 | Oligometastatic Disease State is Associated with Improved Local Control in Patients Undergoing 3 or 5 Fraction Spine Stereotactic Body Radiotherapy |
| Q35164247 | Oligometastatic breast cancer: a shift from palliative to potentially curative treatment? |
| Q26744097 | Optimal Selection of Radiotherapy as Part of a Multimodal Approach for Hepatocellular Carcinoma |
| Q35880933 | Outcomes after Stereotactic Body Radiotherapy versus Limited Resection in Older Patients with Early-Stage Lung Cancer. |
| Q96305367 | Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive Impairments |
| Q36476212 | Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study |
| Q92722967 | Performance and Impact of Prostate Specific Membrane Antigen-Based Diagnostics in the Management of Men with Biochemical Recurrence of Prostate Cancer and its Role in Salvage Lymph Node Dissection |
| Q47110081 | Preliminary comparison of the registration effect of 4D-CBCT and 3D-CBCT in image-guided radiotherapy of Stage IA non-small-cell lung cancer |
| Q41097227 | Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure? |
| Q38241214 | Proton-based stereotactic ablative radiotherapy in early-stage non-small-cell lung cancer |
| Q30416741 | Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary |
| Q47142130 | Quality and safety in stereotactic radiosurgery and stereotactic body radiation therapy: can more be done? |
| Q34005194 | Radiation therapy for liver tumors: ready for inclusion in guidelines? |
| Q33902923 | Radiation-induced changes in the glycome of endothelial cells with functional consequences. |
| Q89596081 | Recent advances in radiation oncology |
| Q55385898 | Retroperitoneal Metastasis Abutting Small Bowel: A Novel Magnetic Resonance-Guided Radiation Approach. |
| Q35970200 | Robotic radiosurgery in pancreatic cancer: A systematic review |
| Q61813694 | Role of radiotherapy in the treatment of metastatic head and neck cancer |
| Q40179018 | SBRT for lung oligometastases: Who is the perfect candidate? |
| Q35200592 | SBRT in operable early stage lung cancer patients. |
| Q55220912 | SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques. |
| Q28088346 | SBRT: A viable option for treating adrenal gland metastases |
| Q57805631 | Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer |
| Q46330953 | Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages. |
| Q98292839 | Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond? |
| Q57020608 | Stereotactic Body Radiation Therapy (SBRT) Using CyberKnife in Oligometastatic Cancer Patients; Retrospective Evaluation, Single Institution Experience |
| Q26771943 | Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: When and Why Is It Appropriate Therapy? |
| Q91675480 | Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer |
| Q64246266 | Stereotactic Radiotherapy for Oligometastasis |
| Q47140283 | Stereotactic ablative body radiotherapy (SABR) for effective palliation of metastases: factors affecting local control |
| Q39598540 | Stereotactic ablative radiotherapy for oligometastatic disease in liver |
| Q37127178 | Stereotactic ablative radiotherapy in the UK: current status and developments |
| Q42857993 | Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes |
| Q36360066 | Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review. |
| Q27008308 | Stereotactic body radiation therapy for liver metastases |
| Q60912983 | Stereotactic body radiation therapy for non-small cell lung cancer: A review |
| Q99361871 | Stereotactic body radiation therapy for oligometastatic gynecologic malignancies: A systematic review |
| Q64096283 | Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications |
| Q37448860 | Stereotactic body radiation therapy induces fast tumor control and symptom relief in patients with iliac lymph node metastasis |
| Q34762699 | Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma |
| Q34320125 | Stereotactic body radiotherapy for oligometastases. |
| Q49356651 | Stereotactic body radiotherapy for stage I non-small cell lung cancer |
| Q26796394 | Stereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: Current evidence and future directions |
| Q58790310 | Stereotactic body radiotherapy using the CyberKnife system in the treatment of patients with liver metastases: state of the art |
| Q37684116 | Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation. |
| Q38367507 | Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future? |
| Q57040824 | Temporal clustering analysis of endothelial cell gene expression following exposure to a conventional radiotherapy dose fraction using Gaussian process clustering |
| Q99623395 | Temporary Organ Displacement to Escalate Radiation Dose to Retroperitoneal Tumors and Decrease Toxicity to Organs at Risk |
| Q89869685 | The changing role of radiation therapy in the management of oligometastatic disease |
| Q55084094 | The role of SBRT in oligometastatic patients with liver metastases from breast cancer. |
Search more.